title: Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
authors.forename: Stefano
authors.initials: S
authors.lastname: Menzo
authors.forename: Donatella
authors.initials: D
authors.lastname: Vincenti
authors.forename: Mariacarmela
authors.initials: M
authors.lastname: Solmone
authors.forename: Mattia
authors.initials: M
authors.lastname: Prosperi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Bruselles
authors.forename: Isabella
authors.initials: I
authors.lastname: Abbate
authors.forename: Gabriella
authors.initials: G
authors.lastname: Rozera
authors.forename: Maria Rosaria
authors.initials: MR
authors.lastname: Capobianchi
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D004279:DNA, Viral / Q000235:genetics; D024882:Drug Resistance, Viral; D006678:HIV / Q000187:drug effects / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D006509:Hepatitis B / Q000188:drug therapy / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D009154:Mutation
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral